Clinical Trial Update: Pilot Study on Trametinib for Surgical Unruptured AVMs [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 pilot study evaluating trametinib for surgical, unruptured arteriovenous malformations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformations

Drugs mentioned

• Trametinib (trametinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Arteriovenous Malformations | Phase 2 | Status: UNKNOWN